Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Companies

Could Jupiter Wellness Inc. (JUPW) stock price achieve new all-time highs if its expected earnings and revenue increase?

January 20, 2023
in Companies

In yesterday’s Wall Street session, Jupiter Wellness Inc. (NASDAQ:JUPW) shares traded at $0.62, down -38.81% from the previous session.

As of this writing, 1 analysts cover Jupiter Wellness Inc. (NASDAQ:JUPW). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.30 and a low of $3.30, we find $3.30. Given the previous closing price of $1.01, this indicates a potential upside of 226.73 percent. JUPW stock price is now -39.26% away from the 50-day moving average and -29.32% away from the 200-day moving average. The market capitalization of the company currently stands at $12.36M.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $3.30 as their price target over the next twelve months.

.

In other news, FANI SKENDER, Director bought 64,060 shares of the company’s stock on Oct 25. The stock was bought for $57,654 at an average price of $0.90. Upon completion of the transaction, the Director now directly owns 122,000 shares in the company, valued at $75640.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 25, Director FANI SKENDER bought 64,060 shares of the business’s stock. A total of $57,654 was incurred on buying the stock at an average price of $0.90. This leaves the insider owning 122,000 shares of the company worth $75640.0. Insiders disposed of 56,496 shares of company stock worth roughly $35027.52 over the past 1 year. A total of 23.30% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in JUPW stock. A new stake in Jupiter Wellness Inc. shares was purchased by MERCER GLOBAL ADVISORS INC /ADV during the first quarter worth $19,000. TRIUMPH CAPITAL MANAGEMENT invested $9,000 in shares of JUPW during the first quarter. In total, there are 22 active investors with 14.40% ownership of the company’s stock.

Thursday morning saw Jupiter Wellness Inc. (NASDAQ: JUPW) opened at $0.7900. During the past 12 months, Jupiter Wellness Inc. has had a low of $0.59 and a high of $1.64. As of last week, the company has a debt-to-equity ratio of 0.22, a current ratio of 2.80, and a quick ratio of 2.70. The fifty day moving average price for JUPW is $1.0174 and a two-hundred day moving average price translates $0.8744 for the stock.

The latest earnings results from Jupiter Wellness Inc. (NASDAQ: JUPW) was released for Jun, 2022. The company reported revenue of $1.57 million for the quarter, compared to $0.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 128.2 percent.

Jupiter Wellness Inc.(JUPW) Company Profile

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company’s clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Tags: Jupiter Wellness Inc.JUPWJUPW stockNASDAQ:JUPW

Related Posts

aTyr Pharma Inc. (LIFE) Holding Strong: What’s pushing it?

January 27, 2023

Stocks of The Vita Coco Company Inc. [COCO] are gaining investors’ attention: here’s why

January 27, 2023

Is IZEA Worldwide Inc. (NASDAQ:IZEA) being unfairly punished by investors?

January 27, 2023

Before Investing In Lakeland Financial Corporation (NASDAQ:LKFN), Here Are Some Things To Consider

January 27, 2023

A secret that hides Histogen Inc.’s strength (NASDAQ:HSTO)

January 27, 2023

Do you still think Veritiv Corporation (NYSE:VRTV) is worth a look?

January 27, 2023
Next Post

A breakdown of the latest mutual funds holding Enel Chile S.A. (ENIC)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Does Aquestive Therapeutics Inc. (NASDAQ:AQST) have deteriorating prospects?

3 days ago

Before Investing In TriMas Corporation (NASDAQ:TRS), Here Are Some Things To Consider

3 days ago

How should investors evaluate LogicMark Inc. (NASDAQ:LGMK)?

2 weeks ago

Do investors have a safe investment in BIMI International Medical Inc. (NASDAQ:BIMI)?

3 months ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch